Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Directorate Change

25 Mar 2010 10:00

RNS Number : 1675J
Byotrol PLC
25 March 2010
 



 

25 March 2010

 

Byotrol plc

Directorate change

 

The Board of Byotrol plc ('Byotrol' or the 'Company'), the leading anti-microbial hygiene company, is pleased to announce the appointment of Dr. Gary Millar as the Company's new Chief Executive Officer. Dr. Millar will join the Company on 1 April 2010.

 

Dr. Millar, aged 48, has a PhD in Biochemistry from Glasgow University. He started his career with ICI plc, where he held several senior managerial positions.

 

In 1998 Dr. Millar joined the Foseco division of Burmah Castrol plc as Supply Chain Director and was subsequently appointed Operations Director of Foseco Jersey Ltd., a private equity backed MBO, which floated on the London Stock Exchange in 2005. Between 2005 - 2007, Dr Millar was Managing Director of Foseco Steel UK Ltd. In 2007 Dr Millar was appointed Group Services Director of Foseco plc, and was a member of Foseco plc's Executive Committee, where he played a key role in Foseco's merger with Cookson plc.

 

In 2008 Dr. Millar founded A K Business Management Limited, a management consultancy providing strategic marketing and operational business solutions to UK SMEs.

 

Dr. Millar is a full member of the Chartered Institute of Marketing and is a member of the Institute of Directors.

 

David McRobbie, Byotrol's current CEO, will remain on the Company board with responsibility for the important US operations, and will re-locate to the USA later this year as CEO of Byotrol Inc.

 

Commenting on the appointments, Ralph Kugler, Chairman, said:

 

"The Board of Directors is delighted to welcome Gary Millar as its new Chief Executive Officer. Gary has had an outstanding career, and combines strong senior management achievement with experience of the Life Sciences sector. Gary has led both small and large businesses, and has an impressive track record of delivering results."

 

"The Board is also pleased that David McRobbie has agreed to relocate to the US to lead Byotrol Inc. Success in the US is a key part of our strategy, and the Board is clear that this can only be achieved with experienced senior leadership. Mr McRobbie will continue to be a member of the Byotrol plc board."

 

 

Details of directorships that Dr. Millar holds, or has held in the previous five years, are given below:

 

Current directorships:

 

AK Business Management Ltd

 

Past directorships:

 

Foseco plc

Foseco (GB) Limited

Foseco (Jersey) Limited

Foseco (MRL) Limited

Foseco (RUL) Limited

Foseco (UK) Limited

Foseco Holding (Europe) Limited

Foseco Holding B.V.

Foseco Holding International Limited

Foseco Holding Limited

Foseco International Limited

Foseco Limited

Foseco Overseas Limited

Foseco Pension Fund Trustee Limited

Foseco Steel (Holdings) China Limited

Foseco Steel (UK) Limited

Foseco Technology Limited

Foseco Transnational Limited

Minerals Separation Limited

New Foseco (UK) Limited

Tamworth UK Limited

Unicorn Industries Limited

 

 

Save for the declarations above there is no further information to be disclosed in respect of the appointment of Dr. Millar under Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

Enquiries:

 

Byotrol plc 0161 277 9518

Ralph Kugler, Non-Executive Chairman

Richard Bell, Finance Director

 

 

Charles Stanley Securities 020 7149 6000

Nominated Adviser

Russell Cook / Carl Holmes

 

Winningtons 020 3043 4162

Tom Cooper / Paul Vann 0797 122 1972

 

 

Notes to Editors:

 

Byotrol Plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a stand alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEANDSAELEEEF
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.